Document Detail


The immature and the mature myocardium. Responses to multidose crystalloid cardioplegia.
MedLine Citation:
PMID:  3352295     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This study was designed to determine whether multidose St. Thomas' Hospital cardioplegic solution is as effective for preservation of the immature myocardium during ischemia as it is for the mature myocardium. An isolated working heart model was used. Sets of six hearts from immature (3 to 4 weeks, 500 gm) and mature (24 weeks, 2 kg) rabbits were subjected to 60, 90, or 120 minutes of ischemia. Myocardial protection consisted of infusion of cardioplegic solution every 30 minutes at 4 degrees C in a dose of 10 ml/kg of animal weight and maintenance of hypothermia at 10 degrees C by immersion in a cold saline bath. The percent recovery of preischemic aortic flow was lower in the immature than the mature hearts after 90 minutes (60.3% +/- 7.4% versus 101.8% +/- 4.3%) and after 120 minutes (57.4% +/- 10.6% versus 91.1% +/- 13.6%) of ischemia (results expressed as mean value +/- standard error of the mean, p less than 0.05). There were no differences between the mature and the immature hearts in the recovery of heart rate, left atrial pressure, mean aortic pressure, or glycogen stores. Adenosine triphosphate levels measured at the end of the experiment were not different from control in the immature hearts subjected to 60 or 90 minutes of ischemia, but did decline after 120 minutes of ischemia (18.5 +/- 0.8, 16.9 +/- 1.3, 16.6 +/- 0.6 versus 12.3 +/- 1.8 mumol/gm dry weight, p less than 0.05). Adenosine triphosphate levels in the mature hearts were lower than control in hearts subjected to 60, 90, and 120 minutes of ischemia (18.0 +/- 1.2 versus 13.6 +/- 1.1, 12.8 +/- 0.9, 13.7 +/- 1.5 mumol/gm dry weight, p less than 0.05). Multidose St. Thomas' Hospital cardioplegia does not provide adequate preservation of hemodynamic function in the immature rabbit heart, even though myocardial high-energy stores are well preserved. Additional work is necessary to clarify the mechanism of this finding and to develop appropriate methods for protection of the immature myocardium.
Authors:
J A Magovern; W E Pae; C A Miller; J A Waldhausen
Related Documents :
8010135 - Ischaemic episodes of less than 5 minutes produce preconditioning but not stunning in t...
8321005 - Protective effects of diltiazem and ryanodine against ischemia-reperfusion injury in ne...
19910005 - Augmentation of systemic blood pressure during spinal cord ischemia to prevent postoper...
1638565 - Endothelium bound extracellular superoxide dismutase type c reduces damage in reperfuse...
11755835 - Latanoprost and brimonidine: therapeutic and physiologic assessment before and after or...
6822925 - Intracranial pressure monitoring as a guide to prognosis in the nearly drowned, severel...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  95     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1988 Apr 
Date Detail:
Created Date:  1988-05-06     Completed Date:  1988-05-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  618-24     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / metabolism
Aging / physiology*
Animals
Bicarbonates / pharmacology
Calcium Chloride / pharmacology
Cardioplegic Solutions / pharmacology*
Glycogen / metabolism
Heart / physiology*
Heart Arrest, Induced*
Hemodynamics / drug effects*
Magnesium / pharmacology
Myocardium / metabolism
Perfusion
Phosphocreatine / metabolism
Potassium Chloride / pharmacology
Rabbits
Sodium Chloride / pharmacology
Time Factors
Chemical
Reg. No./Substance:
0/Bicarbonates; 0/Cardioplegic Solutions; 0/St. Thomas' Hospital cardioplegic solution; 10043-52-4/Calcium Chloride; 56-65-5/Adenosine Triphosphate; 67-07-2/Phosphocreatine; 7439-95-4/Magnesium; 7447-40-7/Potassium Chloride; 7647-14-5/Sodium Chloride; 9005-79-2/Glycogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of diltiazem cardioplegia on global function, segmental contractility, and the area of necro...
Next Document:  The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial pr...